当前位置:首页 - 行情中心 - 振东制药(300158) - 财务分析 - 现金流量表

振东制药

(300158)

  

流通市值:58.40亿  总市值:58.45亿
流通股本:9.91亿   总股本:9.92亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金461,491,033.722,580,213,730.061,822,908,395.791,250,597,839.31
  收到的税费返还4,000,00023,352,697.1421,352,286.7312,665,221.36
  收到其他与经营活动有关的现金11,874,428.3728,052,239.7327,844,827.7720,861,970.38
  经营活动现金流入小计477,365,462.092,631,618,666.931,872,105,510.291,284,125,031.05
  购买商品、接受劳务支付的现金225,753,203.491,246,258,685.43859,989,462.17555,677,523.68
  支付给职工以及为职工支付的现金135,217,681.3537,330,984.65359,753,615.16263,239,406.19
  支付的各项税费20,017,692.57182,355,521.35137,371,150.8977,070,594.37
  支付其他与经营活动有关的现金400,438,761.161,126,153,202.311,117,728,132.64791,077,667.14
  经营活动现金流出小计781,427,338.523,092,098,393.742,474,842,360.861,687,065,191.38
  经营活动产生的现金流量净额-304,061,876.43-460,479,726.81-602,736,850.57-402,940,160.33
二、投资活动产生的现金流量:
  收回投资收到的现金597,000,0003,012,919,6002,626,599,0002,112,499,000
  取得投资收益收到的现金2,862,868.1712,867,180.8610,752,321.848,895,470.02
  处置固定资产、无形资产和其他长期资产收回的现金净额-59,947.131,024,266.1324,266.13
  投资活动现金流入小计599,862,868.173,025,846,727.992,638,375,587.972,121,418,736.15
  购建固定资产、无形资产和其他长期资产支付的现金19,561,814.41179,124,007.07119,587,834.6968,305,950.77
  投资支付的现金673,000,0002,550,022,2002,127,354,9001,708,003,000
  投资活动现金流出小计692,561,814.412,729,146,207.072,246,942,734.691,776,308,950.77
  投资活动产生的现金流量净额-92,698,946.24296,700,520.92391,432,853.28345,109,785.38
三、筹资活动产生的现金流量:
  取得借款收到的现金148,384,300162,158,486.5--
  收到其他与筹资活动有关的现金3,509,752.0436,455,079.6533,210,307.326,254,686.7
  筹资活动现金流入小计151,894,052.04198,613,566.1533,210,307.326,254,686.7
  偿还债务支付的现金-33,965,173.0333,637,40030,637,400
  分配股利、利润或偿付利息支付的现金1,008,244.37713,077.28148,348.21148,348.21
  支付其他与筹资活动有关的现金1,735,783.6266,303,513.2362,831,992.4566,636,021.11
  筹资活动现金流出小计2,744,027.99100,981,763.5496,617,740.6697,421,769.32
  筹资活动产生的现金流量净额149,150,024.0597,631,802.61-63,407,433.36-71,167,082.62
五、现金及现金等价物净增加额-247,610,798.62-66,147,403.28-274,711,430.65-128,997,457.57
  加:期初现金及现金等价物余额491,867,869.21558,015,272.49558,015,272.49558,015,272.49
  期末现金及现金等价物余额244,257,070.59491,867,869.21283,303,841.84429,017,814.92
补充资料:
  净利润--303,086,623.19-6,503,597.16
  资产减值准备-5,597,299.55-10,736,851.69
  固定资产和投资性房地产折旧-89,075,688.96-44,037,416.92
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-89,075,688.96-44,037,416.92
  无形资产摊销-25,508,052.43-11,977,974.05
  长期待摊费用摊销-11,851,010.56-3,711,433.62
  处置固定资产、无形资产和其他长期资产的损失-633,441.94--4,604.73
  固定资产报废损失-143,074.28--24,016.13
  公允价值变动损失--1,586,150.58--1,328,710.16
  财务费用-2,207,915.59-1,230,174.45
  投资损失--10,781,530.12--6,519,141.08
  递延所得税--3,015,355.81-1,084,921.23
  其中:递延所得税资产减少--3,160,732.42-966,779.54
    递延所得税负债增加-145,376.61-118,141.69
  存货的减少-237,151,549.57-185,984,818.62
  经营性应收项目的减少--164,535,938.25--170,981,671.02
  经营性应付项目的增加--347,966,034.3--488,884,420.51
  其他--3,086,630.07--464,784.44
  现金的期末余额-491,867,869.21-429,017,814.92
  减:现金的期初余额-558,015,272.49-558,015,272.49
  现金及现金等价物的净增加额--66,147,403.28--128,997,457.57
公告日期2026-04-212026-04-212025-10-232025-08-25
审计意见(境内)标准无保留意见
TOP↑